Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Bernard Vanhove, Stéphane Marot, Gwénaëlle Evanno, Isabelle Malet, Gaëtane Rouvray, Françoise Shneiker, Edwige Mevel, Carine Ciron, Juliette Rousse, Pierre-Joseph Royer, Elsa Lheriteau, François Raffi, Odile Duvaux, Anne-Geneviève Marcelin, Vincent Calvez

Journal title: bioRxiv

Journal publisher: bioRxiv

Published year: 2022

DOI identifier: 10.1101/2022.01.26.477856